Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

77 projects found matching your search criteria :

  1. Intestinal barrier dysfunction as a risk factor for pancreatic ductal adenocarcinoma: impact of fatty acid intake, with ...

    Call: PRELUDIUM 24 , Panel: NZ4

    Principal investigator: Wojciech Michał Jankowski

    Uniwersytet Medyczny w Łodzi

  2. Identifying early biomarkers and molecular targets for therapeutic intervention in right ventricular dysfunction

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: prof. Przemysław Błyszczuk

    Uniwersytet Jagielloński

  3. A triple agonist of glucagon, GLP-1, and GIP receptors as a novel therapeutic option for the treatment of heart failure ...

    Call: SONATA 20 , Panel: NZ5

    Principal investigator: dr Marta Katarzyna Oknińska

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

  4. 4B for LDs: Biodiversity, Biogenesis, Biodegradation and Biomedicine of lipid droplets in age-dependent vascular dysfunc...

    Call: SONATA BIS 14 , Panel: NZ7

    Principal investigator: dr hab. Marta Zofia Pacia

    Uniwersytet Jagielloński

  5. Vascular dysfunction after breast cancer neoadjuvant chemotherapy.The significance of menopausal status and estrogens.

    Call: SONATA 19 , Panel: NZ4

    Principal investigator: dr Piotr Szczepaniak

    Uniwersytet Jagielloński, Collegium Medicum

  6. Alterations of branched-chain amino acids turnover and its supplementation in the prevention of cardiac dysfunction

    Call: PRELUDIUM 22 , Panel: NZ4

    Principal investigator: Agata Jędrzejewska

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  7. The Role of the Mitochondrial Unfolded Protein Response (UPRmt) in Endothelial Function: a Possible Novel Target for the...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Sylwester Tycjan Mosiołek

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  8. Impact of uremic carbamylation on RAA system and endothelial dysfunction

    Call: OPUS 24 , Panel: NZ4

    Principal investigator: prof. Piotr Mydel

    Uniwersytet Jagielloński

  9. Dysfunction of NFE2L1 and other family members causes damage in dopaminergic neuron function through dysregulated transc...

    Call: PRELUDIUM 21 , Panel: NZ5

    Principal investigator: Kamila Łuczyńska

    Instytut Genetyki i Hodowli Zwierząt PAN

  10. Mechanisms and therapeutic potential of SGLT2/SGLT1 and NHE-1 inhibition in a rat model of heart failure with preserved ...

    Call: OPUS 23 , Panel: NZ5

    Principal investigator: dr hab. Urszula Mackiewicz

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

  11. Mechanisms and consequences of small cerebral blod vessels dysfunction inexperimental hyponatremia in the presence of va...

    Call: SONATA 17 , Panel: NZ4

    Principal investigator: dr Marta Aleksandrowicz

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  12. In the search of specific oxylipin fingerprint reflecting the development of endothelial dysfunction with the use of non...

    Call: SONATA 17 , Panel: NZ5

    Principal investigator: dr Agnieszka Róża Kij

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  13. Keap1-dependent proteopathy as a unifying mechanism of vascular dysfunction

    Call: OPUS 22 , Panel: NZ4

    Principal investigator: dr hab. Anna Maria Grochot-Przęczek

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  14. Role of unconventional myosin VI in development of cardiomyopathy: New insights into understanding of function and dysfu...

    Call: PRELUDIUM BIS 3 , Panel: NZ5

    Principal investigator: prof. Maria Jolanta Rędowicz

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  15. Multilevel molecular analysis of the hepatoprotective effect of medicinal herbs extracts in prevention of liver dysfunct...

    Call: OPUS 22 (LAP) , Panel: NZ9

    Principal investigator: prof. Chandra Shekhar Pareek

    Uniwersytet Mikołaja Kopernika, Wydział Nauk Biologicznych i Weterynaryjnych

  16. Metabolic reprogramming in age-dependent endothelial dysfunction and vascular stiffness; novel mechanism of inflamm-agei...

    Call: MAESTRO 13 , Panel: NZ4

    Principal investigator: prof. Stefan Karol Chłopicki

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  17. Proline metabolism as a novel therapeutic target for diseases associated with mitochondrial dysfunction.

    Call: SONATA BIS 11 , Panel: NZ3

    Principal investigator: dr Karolina Szczepanowska

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

  18. The role of ATP-dependent activation of P2 purinergic receptors in the energetic disturbances in the brain of autistic-l...

    Call: PRELUDIUM 20 , Panel: NZ4

    Principal investigator: Lidia Maria Babiec

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  19. Contribution of extracellular vesicles and exosomal arginase to immune dysfunction in endometriosis

    Call: OPUS 21 , Panel: NZ6

    Principal investigator: dr Małgorzata Maria Czystowska-Kuźmicz

    Warszawski Uniwersytet Medyczny

  20. Function and dysfunction of repeated tracts in non-coding and protein-coding transcripts

    Call: OPUS 21 , Panel: NZ3

    Principal investigator: dr hab. Agnieszka Fiszer

    Instytut Chemii Bioorganicznej PAN

  21. The role of lactate dehydrogenase A in development of endothelial dysfunction in murine model of heart failure

    Call: PRELUDIUM 20 , Panel: NZ5

    Principal investigator: Agnieszka Karolina Karaś

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  22. Aging-associated, specific pathomechanisms of endothelial dysfunction in sepsis: pathway analysis and experimental thera...

    Call: WEAVE-UNISONO , Panel: NZ7

    Principal investigator: prof. Stefan Karol Chłopicki

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  23. LDL-mimetic liposomal contrast agent for MRI-based detection of increased endothelial permeability in the early phase of...

    Call: OPUS 20 , Panel: NZ5

    Principal investigator: dr Anna Bar

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  24. The mechanisms of mitochondrial damage-dependent neuroinflammation in experimental models of Parkinson's disease. The ro...

    Call: OPUS 20 (LAP) , Panel: NZ4

    Principal investigator: prof. Agata Adamczyk

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  25. The role of CD38 in the development of cardiovascular dysfunction

    Call: PRELUDIUM 19 , Panel: NZ3

    Principal investigator: Patrycja Maria Jabłońska

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  26. Characteristics of neurodevelopmental and behavioral changes in the tsc2vu242 zebrafish model of Tuberous Sclerosis Comp...

    Call: ETIUDA 8 , Panel: NZ3

    Principal investigator: Magdalena Anna Senderowska

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  27. Which patients with rheumatoid arthritis or axial spondyloarthritis without classical cardiovascular risk factors have m...

    Call: PRELUDIUM 18 , Panel: NZ5

    Principal investigator: Jarosław Łukasz Nowakowski

    Uniwersytet Jagielloński, Collegium Medicum

  28. Gamma-glutamylcysteine ligase participation in the antioxidant mechanism of action of sulodexide on vascular endothelial...

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Klaudia Katarzyna Bontor

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

  29. Function and phenotype of liver sinusoidal endothelial cells (LSECs) and their role in liver dysfunction development in ...

    Call: PRELUDIUM 18 , Panel: NZ5

    Principal investigator: Kamila Wojnar-Lasoń

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  30. Improving quality of livers procured for transplantation from deceased donors using hypothermic machine perfusion

    Call: SONATA BIS 9 , Panel: NZ5

    Principal investigator: dr hab. Michał Jarosław Grąt

    Warszawski Uniwersytet Medyczny

  31. Comparative evaluation of effects of tyrosine kinase inhibitors (TKIs) on endothelial function in vivo in mice

    Call: PRELUDIUM 17 , Panel: NZ5

    Principal investigator: Brygida Elżbieta Marczyk

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  32. The role of molecular composition of endothelial and pancreatic beta-cell extracellular vesicle in diabetic endothelial ...

    Call: OPUS 17 , Panel: NZ3

    Principal investigator: dr hab. Ewa Łucja Stępień

    Uniwersytet Jagielloński

  33. How dysfunction in the nuclear, RNA degrading enzyme DIS3 leads to mitotic defects creating a possible therapeutic strat...

    Call: SONATINA 3 , Panel: NZ2

    Principal investigator: dr Tomasz M. Kuliński

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

  34. Immune-mediated dysfunction of vascular cells in abdominal aortic aneurysms.

    Call: OPUS 16 , Panel: NZ5

    Principal investigator: prof. Wojciech Szczeklik

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum

  35. Glycocalyx damage - the first stage of pathomechanism of endothelial dysfunction; measurements using capillary electroph...

    Call: PRELUDIUM 16 , Panel: NZ7

    Principal investigator: dr Karolina Martyna Matyjaszczyk-Gwarda

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  36. Fibrosis or senescence- why transcriptionally inactivity of Nrf2 protects against colon dysfunction

    Call: SONATA 14 , Panel: NZ4

    Principal investigator: dr Aleksandra Barbara Piechota-Polańczyk

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  37. Role of angiotensin 1-12 and ACE-independent generation of Angiotensin II in peripheral endothelial dysfunction in heart...

    Call: PRELUDIUM 15 , Panel: NZ4

    Principal investigator: Tasnim Mohaissen

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  38. Towards novel mechanisms of endothelial dysfunction in E3L.CETP mice displaying hyperlipidaemia with human-like lipoprot...

    Call: OPUS 15 , Panel: NZ7

    Principal investigator: prof. Stefan Karol Chłopicki

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  39. Assessment of the usefulness of shear wave sonoelastography in the diagnosis and monitoring of the management of increas...

    Call: PRELUDIUM 14 , Panel: NZ5

    Principal investigator: Anna Olchowy

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Lekarsko-Stomatologiczny

  40. Molecular profile of exosomes present in bronchoalveolar lavage fluid as novel biomarker of immune dysfunction in non-sm...

    Call: OPUS 14 , Panel: NZ6

    Principal investigator: dr Małgorzata Maria Czystowska-Kuźmicz

    Warszawski Uniwersytet Medyczny, I Wydział Lekarski

  41. Dysfunction of pancreatic isles in type 2 diabetes – role of fatty acids and epigenetic mechanisms in maintenance of pan...

    Call: PRELUDIUM 14 , Panel: NZ3

    Principal investigator: Aneta Maria Dobosz

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  42. How microglia-astrocyte interaction affects neuronal functioning in the dopaminergic system. Analysis of the protective ...

    Call: OPUS 14 , Panel: NZ7

    Principal investigator: dr Katarzyna Zofia Kuter

    Instytut Farmakologii PAN

  43. Regulation of vascular smooth muscle cells differentiation and plasticity in physiology and inflammation-induced vascula...

    Call: SONATA 13 , Panel: NZ4

    Principal investigator: dr Anna Filip

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  44. The role of endoplasmic reticulum stress in the pathomechanisms of early-life stress-induced dysfunction of the prefrona...

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Chocyk

    Instytut Farmakologii PAN

  45. Comparative effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ) and olanzapine on the cognitive dysfunction meas...

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Wąsik

    Instytut Farmakologii PAN

  46. Annexins as markers of vascular endothelium dysfunction in insulin resistance induced in vitro

    Call: OPUS 12 , Panel: NZ3

    Principal investigator: dr hab. Joanna Bandorowicz-Pikuła

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  47. Involvement of P2 receptors in pathogenesis of glomerular filtration barrier dysfunction in experimental model of diabet...

    Call: OPUS 12 , Panel: NZ5

    Principal investigator: prof. Maciej Wojciech Jankowski

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  48. Involvement of stearoyl-CoA desaturase-dependent signaling in pericardial and pericoronary adipose tissue and coronary a...

    Call: SONATA BIS 6 , Panel: NZ4

    Principal investigator: prof. Paweł Dobrzyń

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  49. Participation of oxidized low density lipoprotein (oxLDL) in pathogenesis of glomerular filtration barrier dysfunction i...

    Call: PRELUDIUM 11 , Panel: NZ4

    Principal investigator: Kamil Wojciech Dąbkowski

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  50. Role of epigenetic regulation mediated by microRNA in endothelial dysfunction.

    Call: PRELUDIUM 11 , Panel: NZ2

    Principal investigator: Sabina Magdalena Lichołai

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski